 |
 |
|
|
|
| L-Valinol |
 |
| L-Valinol |
 |
| 2026-48-4 |
 |
| pharmaceutical intermediate, mainly used in asymmetric chiral synthesis |
 |
Appearance: white or almost white powder
Assay: ¡Ã99%(HPLC)
Melting point: 30-33¡É
|
|
|
|
 |
|
|
|
|
|
 |
| There are no existing companies to distribute selected chemical product |
|
 |
|
|
|
